Galen Partners Invests in Nautilus Neurosciences, Inc. Funding to Provide Growth Capital for the Launch of CAMBIA™ 13 April 2010
APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the European Approval of Ondansetron RapidFilm™ 23 March 2010
Linkedin